Cargando…
Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women
BACKGROUND: In the United States, over 34 million American post-menopausal women have low bone mass (osteopenia) which increases their risk of osteoporosis and fractures. Calcium, vitamin D and exercise are recommended for prevention of osteoporosis, and bisphosphonates (BPs) are prescribed in women...
Autores principales: | Bilek, Laura D., Waltman, Nancy L., Lappe, Joan M., Kupzyk, Kevin A., Mack, Lynn R., Cullen, Diane M., Berg, Kris, Langel, Meghan, Meisinger, Melissa, Portelli-Trinidad, Ashlee, Lang, Molly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004254/ https://www.ncbi.nlm.nih.gov/pubmed/27576310 http://dx.doi.org/10.1186/s12905-016-0339-x |
Ejemplares similares
-
Retraction: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
por: IWAMOTO, Jun, et al.
Publicado: (2018) -
Emerging evidence on the link between depressive symptoms and bone loss in postmenopausal women
por: Mollard, Elizabeth, et al.
Publicado: (2017) -
In Vivo Evaluation of the Presence of Bone Marrow in Cortical Porosity in Postmenopausal Osteopenic Women
por: Goldenstein, Janet, et al.
Publicado: (2009) -
Comparison of the Mandibular Bone Densitometry Measurement Between Normal, Osteopenic and Osteoporotic Postmenopausal Women
por: Khojastehpour, Leila, et al.
Publicado: (2013) -
FRI681 Osteoboost(Tm) Is Effective In Preserving Bone Strength And Density Of The Spine In Women With Low Bone Mass
por: Bilek, Laura D, et al.
Publicado: (2023)